All News
All series
All All News
Advertisement
Cost of cancer care is a growing concern of both patients and medical professionals.
Ponatinib continues to make improvements in phase 2 CML study.
Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.
A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.
Find information and resources on Medicare.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5